Concepts (258)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chagas Disease | 26 | 2025 | 314 | 6.680 |
Why?
|
| Trypanosoma cruzi | 26 | 2025 | 256 | 6.560 |
Why?
|
| Chagas Cardiomyopathy | 6 | 2021 | 51 | 2.320 |
Why?
|
| Vaccines | 6 | 2023 | 384 | 1.940 |
Why?
|
| Nitroimidazoles | 5 | 2023 | 48 | 1.910 |
Why?
|
| Facial Nerve Injuries | 5 | 2022 | 7 | 1.790 |
Why?
|
| Trypanocidal Agents | 4 | 2023 | 33 | 1.730 |
Why?
|
| Antibodies, Protozoan | 6 | 2025 | 99 | 1.700 |
Why?
|
| Protozoan Vaccines | 11 | 2024 | 99 | 1.680 |
Why?
|
| Motor Neurons | 6 | 2022 | 138 | 1.570 |
Why?
|
| Facial Nucleus | 2 | 2022 | 2 | 1.200 |
Why?
|
| Antibody Formation | 3 | 2025 | 268 | 0.930 |
Why?
|
| Amyotrophic Lateral Sclerosis | 3 | 2018 | 177 | 0.880 |
Why?
|
| Parasites | 2 | 2023 | 35 | 0.840 |
Why?
|
| Superoxide Dismutase | 2 | 2015 | 179 | 0.830 |
Why?
|
| Antigens, Protozoan | 5 | 2024 | 78 | 0.780 |
Why?
|
| Ascaris suum | 3 | 2020 | 32 | 0.760 |
Why?
|
| Animals | 43 | 2025 | 34404 | 0.740 |
Why?
|
| Mice | 26 | 2025 | 18482 | 0.690 |
Why?
|
| Facial Nerve | 2 | 2018 | 25 | 0.670 |
Why?
|
| Mice, Inbred BALB C | 13 | 2025 | 1020 | 0.650 |
Why?
|
| Monkey Diseases | 1 | 2020 | 17 | 0.640 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2019 | 20 | 0.630 |
Why?
|
| Protozoan Proteins | 4 | 2024 | 133 | 0.620 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2019 | 44 | 0.620 |
Why?
|
| Lymphokines | 1 | 2019 | 63 | 0.620 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 233 | 0.600 |
Why?
|
| Microbiota | 2 | 2023 | 441 | 0.590 |
Why?
|
| Protective Agents | 1 | 2018 | 36 | 0.570 |
Why?
|
| HLA-A Antigens | 1 | 2018 | 33 | 0.550 |
Why?
|
| HLA-B Antigens | 1 | 2018 | 30 | 0.550 |
Why?
|
| Immunity, Cellular | 2 | 2022 | 200 | 0.550 |
Why?
|
| Myocardium | 2 | 2019 | 874 | 0.540 |
Why?
|
| Immunoglobulin G | 3 | 2022 | 810 | 0.520 |
Why?
|
| Central Nervous System Diseases | 1 | 2018 | 99 | 0.520 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 463 | 0.500 |
Why?
|
| Ascariasis | 4 | 2020 | 76 | 0.500 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 631 | 0.500 |
Why?
|
| Immunologic Memory | 1 | 2018 | 202 | 0.490 |
Why?
|
| Mice, Inbred C57BL | 8 | 2025 | 4768 | 0.470 |
Why?
|
| Vaccination | 8 | 2022 | 1044 | 0.450 |
Why?
|
| Axotomy | 3 | 2022 | 13 | 0.440 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 496 | 0.390 |
Why?
|
| Leishmania | 2 | 2023 | 33 | 0.390 |
Why?
|
| Leishmaniasis | 2 | 2023 | 40 | 0.390 |
Why?
|
| Nerve Regeneration | 2 | 2019 | 76 | 0.380 |
Why?
|
| Disease Models, Animal | 8 | 2025 | 4685 | 0.370 |
Why?
|
| Interleukin-10 | 3 | 2022 | 185 | 0.370 |
Why?
|
| Heart | 5 | 2023 | 675 | 0.350 |
Why?
|
| Antigens, Helminth | 5 | 2020 | 187 | 0.340 |
Why?
|
| Recombinant Proteins | 5 | 2023 | 1316 | 0.340 |
Why?
|
| Trichuriasis | 3 | 2022 | 31 | 0.330 |
Why?
|
| Immunization | 5 | 2022 | 307 | 0.320 |
Why?
|
| Female | 23 | 2025 | 71214 | 0.310 |
Why?
|
| Antibodies, Helminth | 3 | 2020 | 131 | 0.310 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2022 | 460 | 0.290 |
Why?
|
| B-Lymphocytes | 4 | 2025 | 529 | 0.270 |
Why?
|
| Fibrosis | 2 | 2019 | 416 | 0.270 |
Why?
|
| Superantigens | 2 | 2017 | 20 | 0.250 |
Why?
|
| Wallerian Degeneration | 1 | 2006 | 9 | 0.240 |
Why?
|
| Adjuvants, Immunologic | 5 | 2022 | 393 | 0.240 |
Why?
|
| Cytokines | 4 | 2022 | 1348 | 0.240 |
Why?
|
| RNA, Messenger | 3 | 2024 | 2569 | 0.230 |
Why?
|
| Superoxide Dismutase-1 | 2 | 2016 | 28 | 0.230 |
Why?
|
| Hepatomegaly | 1 | 2023 | 22 | 0.210 |
Why?
|
| Disease Progression | 3 | 2023 | 2221 | 0.200 |
Why?
|
| PPAR alpha | 1 | 2023 | 53 | 0.200 |
Why?
|
| Leishmania mexicana | 1 | 2023 | 4 | 0.200 |
Why?
|
| Interferon-gamma | 4 | 2019 | 542 | 0.190 |
Why?
|
| Th2 Cells | 2 | 2017 | 186 | 0.190 |
Why?
|
| Immunoglobulin M | 3 | 2018 | 213 | 0.190 |
Why?
|
| Neuroprotection | 1 | 2022 | 33 | 0.190 |
Why?
|
| Mutation | 2 | 2017 | 6194 | 0.190 |
Why?
|
| Th1 Cells | 2 | 2022 | 156 | 0.180 |
Why?
|
| RNA, Protozoan | 1 | 2021 | 10 | 0.180 |
Why?
|
| Parasite Load | 2 | 2018 | 31 | 0.170 |
Why?
|
| Metabolome | 2 | 2021 | 329 | 0.170 |
Why?
|
| Mice, Transgenic | 3 | 2016 | 2363 | 0.170 |
Why?
|
| Larva | 2 | 2018 | 252 | 0.170 |
Why?
|
| Tropism | 1 | 2020 | 9 | 0.170 |
Why?
|
| Antigenic Variation | 1 | 2021 | 37 | 0.170 |
Why?
|
| Humans | 22 | 2024 | 131759 | 0.160 |
Why?
|
| Mexico | 2 | 2018 | 198 | 0.160 |
Why?
|
| Interleukin-17 | 1 | 2021 | 128 | 0.160 |
Why?
|
| Flow Cytometry | 2 | 2023 | 769 | 0.160 |
Why?
|
| Phospholipids | 1 | 2020 | 103 | 0.160 |
Why?
|
| Endothelin-1 | 1 | 2019 | 40 | 0.160 |
Why?
|
| Cysteine | 2 | 2017 | 140 | 0.150 |
Why?
|
| Seroepidemiologic Studies | 1 | 2020 | 167 | 0.150 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 140 | 0.150 |
Why?
|
| Parasitemia | 1 | 2019 | 26 | 0.150 |
Why?
|
| Male Urogenital Diseases | 1 | 2019 | 15 | 0.150 |
Why?
|
| Helminth Proteins | 1 | 2020 | 104 | 0.150 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2018 | 358 | 0.150 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2019 | 37 | 0.150 |
Why?
|
| Mice, Inbred ICR | 1 | 2019 | 152 | 0.150 |
Why?
|
| Antibodies, Catalytic | 1 | 2018 | 7 | 0.150 |
Why?
|
| Swine Diseases | 1 | 2018 | 40 | 0.140 |
Why?
|
| Macaca mulatta | 1 | 2020 | 496 | 0.140 |
Why?
|
| Electric Stimulation Therapy | 1 | 2019 | 85 | 0.140 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2019 | 173 | 0.140 |
Why?
|
| Spatio-Temporal Analysis | 1 | 2018 | 19 | 0.140 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 792 | 0.140 |
Why?
|
| Immunity | 1 | 2018 | 179 | 0.140 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2018 | 132 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 2 | 2018 | 1489 | 0.130 |
Why?
|
| Cell Death | 1 | 2018 | 237 | 0.130 |
Why?
|
| Immunophenotyping | 1 | 2018 | 336 | 0.130 |
Why?
|
| Spinal Cord | 1 | 2018 | 269 | 0.130 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2018 | 199 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 1005 | 0.130 |
Why?
|
| Host-Parasite Interactions | 1 | 2016 | 72 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2018 | 450 | 0.120 |
Why?
|
| Vaccines, Synthetic | 4 | 2022 | 321 | 0.120 |
Why?
|
| Trichuris | 3 | 2022 | 26 | 0.120 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2017 | 154 | 0.120 |
Why?
|
| Insect Vectors | 1 | 2016 | 106 | 0.120 |
Why?
|
| Gene Frequency | 1 | 2018 | 750 | 0.120 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 1610 | 0.120 |
Why?
|
| Laser Capture Microdissection | 1 | 2015 | 8 | 0.120 |
Why?
|
| Mice, Knockout | 2 | 2022 | 3864 | 0.120 |
Why?
|
| Motor Disorders | 1 | 2015 | 8 | 0.120 |
Why?
|
| Fibroblasts | 1 | 2019 | 864 | 0.110 |
Why?
|
| Motor Activity | 1 | 2018 | 508 | 0.110 |
Why?
|
| Cell Survival | 1 | 2018 | 854 | 0.110 |
Why?
|
| Sensation Disorders | 1 | 2015 | 24 | 0.110 |
Why?
|
| Th17 Cells | 1 | 2016 | 95 | 0.110 |
Why?
|
| Spinal Cord Injuries | 1 | 2018 | 278 | 0.110 |
Why?
|
| Swine | 1 | 2018 | 1190 | 0.110 |
Why?
|
| Muscle Strength | 1 | 2015 | 82 | 0.110 |
Why?
|
| Acute Disease | 1 | 2018 | 1153 | 0.110 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 673 | 0.110 |
Why?
|
| Echocardiography | 1 | 2019 | 1138 | 0.100 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2023 | 694 | 0.100 |
Why?
|
| Transfection | 1 | 2015 | 960 | 0.100 |
Why?
|
| Vaccines, Combined | 2 | 2023 | 39 | 0.100 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 236 | 0.100 |
Why?
|
| Histamine Release | 1 | 2012 | 10 | 0.100 |
Why?
|
| Basophils | 1 | 2012 | 14 | 0.090 |
Why?
|
| Hookworm Infections | 1 | 2014 | 125 | 0.090 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2012 | 28 | 0.090 |
Why?
|
| Necator americanus | 1 | 2012 | 91 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 1 | 2018 | 1745 | 0.090 |
Why?
|
| Immunotherapy | 1 | 2017 | 765 | 0.090 |
Why?
|
| Genotype | 1 | 2018 | 2656 | 0.090 |
Why?
|
| Global Health | 1 | 2016 | 632 | 0.090 |
Why?
|
| HIV Infections | 1 | 2024 | 2037 | 0.090 |
Why?
|
| Immunoglobulin E | 1 | 2012 | 225 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2018 | 1561 | 0.080 |
Why?
|
| Male | 5 | 2020 | 65274 | 0.080 |
Why?
|
| Lung | 1 | 2018 | 1566 | 0.080 |
Why?
|
| Cell Proliferation | 1 | 2018 | 2483 | 0.080 |
Why?
|
| Interleukin-4 | 2 | 2022 | 145 | 0.080 |
Why?
|
| Biomarkers | 1 | 2019 | 3407 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2015 | 724 | 0.080 |
Why?
|
| Age Factors | 1 | 2015 | 2872 | 0.070 |
Why?
|
| Leishmania major | 1 | 2007 | 27 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 3916 | 0.070 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 2007 | 49 | 0.070 |
Why?
|
| Pregnancy | 1 | 2020 | 7576 | 0.060 |
Why?
|
| Soil | 2 | 2020 | 77 | 0.060 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2006 | 60 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 1965 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2007 | 234 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2007 | 432 | 0.060 |
Why?
|
| Forkhead Transcription Factors | 1 | 2007 | 372 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2024 | 115 | 0.050 |
Why?
|
| Technology | 1 | 2024 | 69 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2006 | 681 | 0.050 |
Why?
|
| Dogs | 2 | 2016 | 630 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2024 | 366 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2017 | 1521 | 0.050 |
Why?
|
| Campylobacter jejuni | 1 | 2003 | 6 | 0.050 |
Why?
|
| Campylobacter Infections | 1 | 2003 | 33 | 0.050 |
Why?
|
| Sus scrofa | 1 | 2003 | 115 | 0.050 |
Why?
|
| HIV | 1 | 2024 | 179 | 0.050 |
Why?
|
| Antiparasitic Agents | 1 | 2022 | 28 | 0.050 |
Why?
|
| Mice, Inbred AKR | 1 | 2022 | 16 | 0.050 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2024 | 517 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2022 | 88 | 0.040 |
Why?
|
| Administration, Intranasal | 1 | 2022 | 130 | 0.040 |
Why?
|
| Hybridomas | 1 | 2021 | 39 | 0.040 |
Why?
|
| Immunity, Mucosal | 1 | 2022 | 90 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2020 | 17662 | 0.040 |
Why?
|
| Synteny | 1 | 2021 | 69 | 0.040 |
Why?
|
| Immunoglobulin A | 1 | 2022 | 210 | 0.040 |
Why?
|
| Epitopes | 1 | 2022 | 432 | 0.040 |
Why?
|
| RNA | 1 | 2024 | 531 | 0.040 |
Why?
|
| Colon | 1 | 2003 | 361 | 0.040 |
Why?
|
| Multigene Family | 1 | 2021 | 290 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 2 | 2021 | 1010 | 0.040 |
Why?
|
| Aged | 1 | 2018 | 21259 | 0.040 |
Why?
|
| Neurotrophin 3 | 1 | 2018 | 13 | 0.040 |
Why?
|
| Thoracic Vertebrae | 1 | 2018 | 67 | 0.030 |
Why?
|
| Schwann Cells | 1 | 2018 | 62 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2017 | 51 | 0.030 |
Why?
|
| Phylogeny | 1 | 2020 | 709 | 0.030 |
Why?
|
| Cholera Toxin | 1 | 2017 | 43 | 0.030 |
Why?
|
| Neuromuscular Junction | 1 | 2018 | 96 | 0.030 |
Why?
|
| Middle Aged | 1 | 2018 | 28892 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 460 | 0.030 |
Why?
|
| Interleukin-5 | 1 | 2017 | 51 | 0.030 |
Why?
|
| Hydrolysis | 1 | 2017 | 141 | 0.030 |
Why?
|
| Dendrites | 1 | 2018 | 182 | 0.030 |
Why?
|
| Dependovirus | 1 | 2018 | 157 | 0.030 |
Why?
|
| Coyotes | 1 | 2016 | 3 | 0.030 |
Why?
|
| Animals, Domestic | 1 | 2016 | 37 | 0.030 |
Why?
|
| Drug Carriers | 1 | 2017 | 117 | 0.030 |
Why?
|
| Adult | 1 | 2018 | 31700 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 279 | 0.030 |
Why?
|
| T-Lymphocytopenia, Idiopathic CD4-Positive | 1 | 2016 | 2 | 0.030 |
Why?
|
| Serine | 1 | 2017 | 163 | 0.030 |
Why?
|
| Triatoma | 1 | 2016 | 30 | 0.030 |
Why?
|
| Housing | 1 | 2016 | 72 | 0.030 |
Why?
|
| Synaptic Transmission | 1 | 2018 | 329 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2017 | 421 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 328 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2017 | 595 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 2565 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 1146 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2016 | 335 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2015 | 201 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1948 | 0.030 |
Why?
|
| Adenoviridae | 1 | 2017 | 582 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2017 | 405 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2017 | 437 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2016 | 291 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2017 | 411 | 0.030 |
Why?
|
| Ascaris lumbricoides | 1 | 2014 | 19 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2017 | 901 | 0.030 |
Why?
|
| Anthelmintics | 1 | 2014 | 55 | 0.030 |
Why?
|
| Ancylostomatoidea | 1 | 2014 | 62 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2018 | 2969 | 0.020 |
Why?
|
| Alum Compounds | 1 | 2012 | 43 | 0.020 |
Why?
|
| Pichia | 1 | 2012 | 56 | 0.020 |
Why?
|
| Vaccines, Subunit | 1 | 2012 | 72 | 0.020 |
Why?
|
| Cricetinae | 1 | 2012 | 367 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 2012 | 159 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2018 | 1004 | 0.020 |
Why?
|
| Prevalence | 1 | 2016 | 2695 | 0.020 |
Why?
|
| Hypersensitivity | 1 | 2012 | 231 | 0.020 |
Why?
|
| Skin | 1 | 2012 | 553 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3451 | 0.020 |
Why?
|
| United States | 1 | 2024 | 11812 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3622 | 0.020 |
Why?
|
| Gene Expression | 1 | 2012 | 1502 | 0.020 |
Why?
|
| Interleukin-4 Receptor alpha Subunit | 1 | 2007 | 13 | 0.020 |
Why?
|
| Ear | 1 | 2007 | 27 | 0.020 |
Why?
|
| Dermis | 1 | 2007 | 28 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2007 | 123 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 2353 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2007 | 96 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2007 | 376 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2003 | 314 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12993 | 0.010 |
Why?
|
| Inflammation | 1 | 2007 | 1493 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3416 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2007 | 4683 | 0.010 |
Why?
|